Primary |
Product Used For Unknown Indication |
49.2% |
Essential Thrombocythaemia |
31.3% |
Thrombocytosis |
5.1% |
Hypertension |
3.0% |
Myelofibrosis |
1.3% |
Bronchitis |
1.0% |
Myeloproliferative Disorder |
1.0% |
Prophylaxis |
1.0% |
Thrombocytopenia |
1.0% |
Bronchitis Chronic |
0.7% |
Chronic Obstructive Pulmonary Disease |
0.7% |
Diabetes Mellitus |
0.7% |
Peripheral Arterial Occlusive Disease |
0.7% |
Pulmonary Embolism |
0.7% |
Renal Failure |
0.7% |
Thrombosis |
0.7% |
Angina Pectoris |
0.3% |
Anxiety Disorder |
0.3% |
Arrhythmia |
0.3% |
Atrial Fibrillation |
0.3% |
|
Myelofibrosis |
10.9% |
Breast Cancer |
6.5% |
Coronary Artery Disease |
6.5% |
Gastrointestinal Haemorrhage |
6.5% |
Myocardial Infarction |
6.5% |
Rectal Haemorrhage |
6.5% |
Thrombocytopenia |
6.5% |
Hospitalisation |
4.3% |
Hypertension |
4.3% |
Palpitations |
4.3% |
Platelet Count Increased |
4.3% |
Pulmonary Oedema |
4.3% |
Skin Ulcer |
4.3% |
Splenic Vein Thrombosis |
4.3% |
Syncope |
4.3% |
Transient Ischaemic Attack |
4.3% |
Vomiting |
4.3% |
Acute Coronary Syndrome |
2.2% |
Acute Myocardial Infarction |
2.2% |
Angina Pectoris |
2.2% |
|
Secondary |
Product Used For Unknown Indication |
33.2% |
Essential Thrombocythaemia |
20.1% |
Hypertension |
11.7% |
Breast Cancer |
7.0% |
Thrombocytosis |
4.2% |
Hypercholesterolaemia |
3.4% |
Myelofibrosis |
2.1% |
Prostate Cancer |
2.1% |
Drug Use For Unknown Indication |
1.8% |
Bronchitis Chronic |
1.6% |
Embolic Stroke |
1.6% |
Prophylaxis |
1.6% |
Thromboembolic Stroke |
1.6% |
Thrombosis |
1.6% |
Breast Cancer Female |
1.3% |
Cerebrovascular Accident |
1.0% |
Chronic Obstructive Pulmonary Disease |
1.0% |
Osteoporosis Prophylaxis |
1.0% |
Peripheral Arterial Occlusive Disease |
1.0% |
Thrombocythaemia |
1.0% |
|
Renal Failure |
12.7% |
Palpitations |
10.9% |
Oesophagitis |
7.3% |
Transient Ischaemic Attack |
7.3% |
Lung Infection |
5.5% |
Malignant Neoplasm Progression |
5.5% |
Skin Ulcer |
5.5% |
Tachycardia |
5.5% |
Ventricular Extrasystoles |
5.5% |
White Blood Cell Count Decreased |
5.5% |
Acute Coronary Syndrome |
3.6% |
Acute Myeloid Leukaemia |
3.6% |
Pancytopenia |
3.6% |
Pulmonary Arterial Hypertension |
3.6% |
Syncope |
3.6% |
Viral Infection |
3.6% |
Asthenia |
1.8% |
Bronchioloalveolar Carcinoma |
1.8% |
Cerebral Haemorrhage |
1.8% |
Condition Aggravated |
1.8% |
|
Concomitant |
Bipolar Disorder |
17.6% |
Chronic Myeloid Leukaemia |
11.8% |
Essential Thrombocythaemia |
11.8% |
Autoimmune Thyroiditis |
5.9% |
Bipolar I Disorder |
5.9% |
Cardiovascular Disorder |
5.9% |
Hepatitis B |
5.9% |
Hypertension |
5.9% |
Interstitial Lung Disease |
5.9% |
Mania |
5.9% |
Myelofibrosis |
5.9% |
Thrombocythaemia |
5.9% |
Thrombocytosis |
5.9% |
|
Weight Increased |
28.6% |
Pancreatitis Acute |
14.3% |
Renal Failure |
14.3% |
Tachycardia |
14.3% |
Urinary Retention |
14.3% |
Vertigo |
14.3% |
|